Science in GU Oncology
A monthly newsletter from Bishoy M. Faltas, MD
A curated monthly perspective on emerging science, translational advances, and practice-shaping research across genitourinary oncology.
Latest Issue
Issue 01 · June 2026
In this edition: CREST, a global, phase 3 randomized trial of subcutaneous sasanlimab combined with BCG induction and maintenance versus...
Read the Latest Issue
High-risk NMIBC treated with BCG induction and maintenance carries an... Read More.
Approximately half of patients with MIBC are ineligible for or... Read More.
AR blockade upregulates PSMA receptor expression in mCRPC. Baseline PSMA... Read More.
The clonal origins of individual metastases, whether seeded directly from... Read More.
Bishoy M. Faltas, MD
Chief Research Officer, Englander Institute for Precision Medicine
Director, Bladder Cancer Research, Englander Institute for Precision Medicine
Gellert Family-John P. Leonard, MD Research Scholar in Hematology and Medical Oncology
Associate Professor of Medicine, Cell and Developmental Biology
Listen to This Month's Commentary
Coming Soon